Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SALLINGVEJ DYREKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   2.9% 2.4% 1.8% 1.4% 5.9% 3.8% 13.7% 13.7%   Credit score (0-100)   60 65 71 76 38 50 16 16   Credit rating   BBB BBB A A BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 1.8 18.2 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,401 4,548 5,071 5,247 4,658 4,860 0.0 0.0   EBITDA   890 714 1,263 1,022 -421 182 0.0 0.0   EBIT   787 602 1,118 846 -598 42.7 0.0 0.0   Pre-tax profit (PTP)   762.9 577.8 1,098.3 820.6 -603.8 42.0 0.0 0.0   Net earnings   593.0 449.8 855.6 640.1 -471.2 32.7 0.0 0.0   Pre-tax profit without non-rec. items   763 578 1,098 821 -604 42.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   416 573 675 733 629 396 0.0 0.0   Shareholders equity total   510 841 1,456 1,241 769 802 677 677   Interest-bearing liabilities   0.3 0.3 0.0 0.0 59.7 0.0 0.0 0.0   Balance sheet total (assets)   1,681 1,915 3,311 2,521 1,551 1,702 677 677   Net Debt   -297 -385 -1,750 -914 -84.6 -336 -677 -677     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,401 4,548 5,071 5,247 4,658 4,860 0.0 0.0   Gross profit growth   28.3% 3.3% 11.5% 3.5% -11.2% 4.3% -100.0% 0.0%   Employees   12 13 15 11 13 13 0 0   Employee growth %   0.0% 5.5% 17.2% -25.4% 18.2% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,681 1,915 3,311 2,521 1,551 1,702 677 677   Balance sheet change%   36.1% 14.0% 72.9% -23.9% -38.5% 9.7% -60.2% 0.0%   Added value   889.9 714.1 1,263.0 1,021.6 -422.6 182.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -44 45 -43 -117 -282 -372 -396 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   17.9% 13.2% 22.0% 16.1% -12.8% 0.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   53.0% 34.1% 43.2% 29.4% -29.4% 2.6% 0.0% 0.0%   ROI %   166.0% 85.3% 94.3% 61.1% -56.3% 5.1% 0.0% 0.0%   ROE %   68.0% 66.6% 74.5% 47.5% -46.9% 4.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   30.3% 43.9% 44.0% 49.2% 49.6% 47.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -33.3% -53.9% -138.5% -89.4% 20.1% -184.3% 0.0% 0.0%   Gearing %   0.1% 0.0% 0.0% 0.0% 7.8% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   16.7% 12,818.8% 22,608.9% 0.0% 18.5% 2.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.6 0.8 1.1 0.9 0.4 0.8 0.0 0.0   Current Ratio   0.9 1.1 1.3 1.3 0.9 1.3 0.0 0.0   Cash and cash equivalent   296.9 385.0 1,749.7 913.8 144.3 336.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -85.7 95.0 613.7 345.8 -77.4 241.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   75 57 86 93 -33 14 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   75 57 86 93 -32 14 0 0   EBIT / employee   66 48 76 77 -46 3 0 0   Net earnings / employee   50 36 58 58 -36 3 0 0